Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol add-on therapy to prevent cardiomyopathy in Duchenne muscular dystrophy
2020-004901-29Phase 3Active
- Sponsor
- Medical University of Gdańsk
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Metoprolol succinate plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Change in left ventricular ejection fraction. Started Jan 2021; status: active.
02
Drugs
metoprolol
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2020-004901-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004901-29.